Chemclin Diagnostics Co., Ltd. (SHA:688468)
China flag China · Delayed Price · Currency is CNY
6.61
-0.08 (-1.20%)
Oct 8, 2026, 2:04 PM CST

Chemclin Diagnostics Company Description

Chemclin Diagnostics Co., Ltd. engages in the research, development, production, and sale of clinical immuno chemiluminescence diagnostic reagents and instruments in China.

The company offers the LiCA series of diagnostic reagents, which is based on photo-induced chemiluminescence; the Chemclin series of diagnostic reagents and instruments, which is based on enzyme-catalyzed chemiluminescence; and routine clinical chemistry diagnostic reagents.

Its products are used for the detection of biomarkers for infectious diseases, such as hepatitis B, hepatitis C, HIV, syphilis, hepatitis A, and hepatitis E, etc., as well as of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation.

The company serves large and medium-sized hospitals, health check-up centers, emergency rooms, clinical laboratories, emergency departments, chest pain centers, and community centers.

Chemclin Diagnostics Co., Ltd. was founded in 2005 and is headquartered in Beijing, China.

Chemclin Diagnostics Co., Ltd.
CountryChina
Founded2005
IndustryDiagnostics & Research
SectorHealthcare
Employees573
CEOLin Li

Contact Details

Address:
Incubation Bldg
Beijing, 100094
China
Phone86 10 5871 7511
Websitechemclin.com

Stock Details

Ticker Symbol688468
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100005311
SIC Code3845

Key Executives

NamePosition
Lin LiChairman and GM
Yanling HuangChief Financial Officer, Secretary and Director
Zheng Ming HuangDeputy GM and Director
Li JinAccounting Supervisor
Zifu LianCore Technical Personnel
Yu Hui LiuCore Technical Personnel